Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lexanersen - WaVe Life Sciences

Next Previous
Search
Drug Profile

Lexanersen - WaVe Life Sciences

Alternative Names: BMTR-5149; Lexanersen sodium; WV-2603; WVE-120102

Latest Information Update: 28 Mar 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator WaVe life Sciences
  • Class Antisense oligonucleotides; Neuroprotectants
  • Mechanism of Action RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Huntington's disease
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Huntington's disease

Most Recent Events

  • 31 Jul 2023 Wave Life Sciences terminates its collaboration with Takeda with respect to C9 Target and ATXN3 Target
  • 16 Jun 2021 Wave Life Sciences terminates a phase I/II trial in Huntington's disease in Australia, Canada, Denmark, France, Germany Poland and the UK (Intrathecal) due to lack of efficacy (NCT04617860)
  • 10 May 2021 WaVe life Sciences terminates a phase Ib/IIa trial in Huntington's disease in USA, Australia, Canada, Denmark, France, Germany, Poland and United Kingdom (Intrathecal, Injection) (NCT03225846) (EudraCT2016-005142-39)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top